Isofol Medical AB (OSTO:ISOFOL) Additional Paid-In Capital : kr1,218.28 Mil(As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Isofol Medical AB Additional Paid-In Capital?

Isofol Medical AB's quarterly additional paid-in capital increased from Sep. 2023 (kr1,217.61 Mil) to Dec. 2023 (kr1,218.28 Mil) but then stayed the same from Dec. 2023 (kr1,218.28 Mil) to Mar. 2024 (kr1,218.28 Mil).

Isofol Medical AB's annual additional paid-in capital increased from Dec. 2021 (kr1,217.61 Mil) to Dec. 2022 (kr1,218.28 Mil) but then stayed the same from Dec. 2022 (kr1,218.28 Mil) to Dec. 2023 (kr1,218.28 Mil).

Isofol Medical AB Additional Paid-In Capital Historical Data

The historical data trend for Isofol Medical AB's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Isofol Medical AB Additional Paid-In Capital Chart

Isofol Medical AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

619.00

768.08

1,217.61

1,218.28

Isofol Medical AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial															1,217.61	1,217.61	1,217.61	1,218.28	1,218.28

Isofol Medical AB Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Isofol Medical AB Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Isofol Medical AB's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Isofol Medical AB (OSTO:ISOFOL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Isofol Medical AB (OSTO:ISOFOL) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

5IU:Germany

Address

Arvid Wallgrens Backe 20, Biotech Center, Gothenburg, SWE, SE-413 46

Website

http://www.isofol.se

Isofol Medical AB is a pharmaceutical company. It is a manufacturer of folate-based therapies. The company's drug candidate Modufolin enhances the effect of the current chemotherapy treatment for patients treated for colorectal cancer. Its products are used to increase efficacy and reduce the side effects of antimetabolite cancer treatment.

Isofol Medical AB (OSTO:ISOFOL) Headlines

No Headlines